The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I don't see myself as an idiot, getting a little impatient, yes :).
On paper this has:-
A deal that may or may not go through for an undetermined amount. Which does sound terrible when you say it, pretty much the linchpin.
A range of projects which Reabold refuses to road map, in part due to funds / too many pots to fill (again sounds bad tbh).
WN Planning is done, in my head the site is next year + drilling time (that is if we are developing it .. who knows maybe another test drill, strike oil and we walk away with a deal ... optimism :D)
So yeah risky biscuits with potential, at least its not a one trick pharma waiting of FDA results over and over. The greed of picking a multi bagger, going all in only to become stuck, is the monster we all have to resist ^^.
Anyway time for homemade pizza, then out for booze and live music.
I don't think they are idiots, I find it impressive how information can be controlled via partial ownership thereby suppressing the share price (something to note investing in other shares). It is pain for short term scalping (at least I got a good chunk at 0.11), and a test of willpower for a holder. If it works out you're an early adopter if not ... ouchie. The potential is there, will it be realised without getting screwed over, this is the constant itch investing in AIM.
Happy with my risk, but the share price (whatever they say in interviews), heck shareholders do not seem to be on the priority list. Lets hope its because of a big wad of cash / farm in opportunity on the way. If I knew the answer I would be buying or selling ^^.
A few years ago, Faron could get away with stating 'Partners' are circling. Now shareholders want a bit more than a cheeky smile. For me all these micro studies are to store up a case for maximizing a Partner deal. Bluff or a waiting game this is the risk you take.
It looks like they brought forward the RNS by a few weeks, which is of minor interest (start the slate clean). Always worst being almost there at the same time everything is hinged on one event. To be fair the full year results always looked backwards, its just getting a touch salty to hear it now after multiple interviews and RNS's confirming the same info. Thankfully not to far under at all, and still feels like it is a great time to be in so ... back to waiting (I would say that ^^). GL everyone!
As a small investor I was very interested the various businesses but this is turning out to be as dull as ditch water. :D.
Its when you do a bit of house keeping and do some small topups in the morning, and they are all the shares traded.
Seems to be a waste of a patent year after year, hopefully things get moving. Totally stacked here, back to the draw they go ^^.
Nice bonus this will progress other projects, victory farm out too. Why flip everything when opportunities are drying up? I wonder if they have changed views on a flip for WN, just farm that too.
Well done all REAL holders :D.
AAOG is worlds apart, I did a cheeky day trade on it once, then I was in it for a month or two (very small amounts). Directors were too spivy for me. Outrageous dividend claims on one unproven well. Turned out they were not good for shareholders after all.
If you're referring to West Newton News, that's nothing to do with it being an 'AIM Stock' its called Engineering. Lots of things are going on in the background but not report worthy. They have either prepped, or are doing detail design. Then the tender process with site contractors and ordering parts. At a minimum the visual blocks would have to be in place (bunds and trees). I am thinking a bit over a year before drilling starts or more if we need another drill at site B. For site B hiring kit or some more testing. If it's another drill exploration, I would guess that will be a high priority. Getting that data processed to help with targeting the first commercial drill is starting to get tight based on the previous timescales :D.
Just chill, or sell up.
Like the reference to manufacturing, and pushing treatment earlier into the tumours development. If these drugs get through the trials, or a big positive, I can't see funding being a problem. It all comes down to risk, as always with trading.
630k dead and the US finally starts a trail. Fast tracking therapeutics for the masses was clearly not a thing.
The reaction is not a surprise, this provides UJO with stability not multibagging. Good luck to them, still WN for the bank, then develop Bis to go. But yeah, if actors wasted months de-ramping RBD hoping to get a great ratio to jump ship, they probably should have filled in paid surveys instead.
Definitely feeling relaxed with this one. Can't see me heavily top slicing like in the old days, if its going to plod along like this. Lovely.